Compare MDXG & CHCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDXG | CHCT |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 530.2M | 514.6M |
| IPO Year | 2007 | 2015 |
| Metric | MDXG | CHCT |
|---|---|---|
| Price | $4.12 | $18.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $9.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 1.2M | 182.8K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 11.07% |
| EPS Growth | 14.29 | ★ 134.78 |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $418,630,000.00 | $121,195,000.00 |
| Revenue This Year | N/A | $9.06 |
| Revenue Next Year | $13.02 | $8.61 |
| P/E Ratio | ★ N/A | $254.43 |
| Revenue Growth | ★ 19.99 | 4.67 |
| 52 Week Low | $3.03 | $13.23 |
| 52 Week High | $7.99 | $18.67 |
| Indicator | MDXG | CHCT |
|---|---|---|
| Relative Strength Index (RSI) | 63.24 | 54.48 |
| Support Level | $3.50 | $16.45 |
| Resistance Level | $5.31 | $18.06 |
| Average True Range (ATR) | 0.14 | 0.37 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 72.97 | 49.39 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. The company derives the majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.